| Application no. and date | 19732147.4 (espacenet) (Federated) (European Patent Register), 20190424 | | Patent/reg. no. and date | DK/EP 3856774, 20221102 | | Publication date | 20210804 | | Priority no. and date | US 201862745914 P, 20181015 | | EP pub. no. and date |
EP 3856774 20210804 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | V451226DK00 | | Inventor | SMITT, Melanie, c/o Genentech, Inc.
1 Dna Way
South San Francisco, CA 94080, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5365 (2006.01) , A61K 39/00 (2006.01) , A61P 31/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/32 (2006.01) | | Title | Fremgangsmåder til behandling af resterende brystcancer med trastuzumba-emtansin | | Int. application no. | US2019028953 | | Int. publication no. | WO2020081119 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
